5 Results for "

GID4 E3 ligase

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "GID4 E3 ligase" in MCE Product Catalog:

Cat. No.: HY-174996
CAS No.: 3031840-36-2
Research Areas:  

Cancer

NEP162 is a BRD4 PROTAC degrader based on the E3 ubiquitin ligase GID4, with DC50 values of 1.2 μM and 1.6 μM in SW480 and U2OS cells, respectively, and a Kd value of 0.13 µM for GID4. NEP162 bridges the E3 ligase GID4 and BRD4 to form a ternary complex, promotes polyubiquitination and subsequent degradation of BRD4 via the ubiquitin-proteasome system, reduces the proliferation capacity of tumor cells and induces apoptosis. NEP162 can be used for research on cancers such as osteosarcoma, colorectal cancer and non-small cell lung cancer .
loading...
    loading...
Cat. No.: HY-180960
CAS No.: 3031840-41-9
Target:  

PROTACs SWI/SNF Complex

Research Areas:  

Cancer

NEP202 is a SMARCA2 PROTAC degrader designed based on the GID4 E3 ligase. NEP168 can be used for cancer research .
loading...
    loading...
Cat. No.: HY-180959
CAS No.: 3031840-37-3
Research Areas:  

Cancer

NEP168 is an ERα PROTAC degrader designed based on the GID4 E3 ligase. NEP168 can be used for the study of breast cancer .
loading...
    loading...
Cat. No.: HY-174997
Research Areas:  

Cancer

PFI-7-O-C4-piperazin is a E3 ligase ligand-linker conjugate that can be used for synthesis of PROTACs, such as NEP162 (HY-174996). The E3 ligase ligand (PFI-7) of NEP162 is a highly selective antagonist of GID4 (KD = 0.22 μM). NEP162 is a BRD4 PROTAC degrader with anti-tumor activity [1] .
loading...
    loading...
Cat. No.: HY-180957
CAS No.: 3031840-31-7
Research Areas:  

Cancer

NEP108 is a GID4 E3 ligase-based BRD4 PROTAC degrader, with its DC50 value approximately 3.8 μM. NEP108 has a strong affinity for GID4, with a KD value of 0.22 μM, and the KD value of its trimeric complex is 2.85 μM. NEP108 can be used for cancer research .
loading...
    loading...